DEVELOPMENT OF A MOLECULAR TARGETED CYTOKINE THAT SPECIFICALLY EXPANDS VGAMMA9VDELTA2 T CELLS AND POTENTIATES ANTI-TUMOR ACTIVITY

被引:0
|
作者
Becklund, Bryan [1 ]
Robinson, Kaitlyn [1 ]
Jones, Kyle [1 ]
Sanabria, Angelica [1 ]
Torretti, Elisebeth [1 ]
Eckles, Andrew [1 ]
Hussain, Abrahim [1 ]
Ahn, Sae Jeong [1 ]
Pandit, Rajay [1 ]
Sulzmaier, Florian [1 ]
Timmer, John [1 ]
Eckelman, Brendan [1 ]
机构
[1] Inhibrx, La Jolla, CA USA
关键词
D O I
10.1136/jitc-2022-SITC2022.1077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1077
引用
收藏
页码:A1119 / A1119
页数:1
相关论文
共 50 条
  • [21] Tumor cell-targeted STING-agonist antibody-drug conjugates achieve potent anti-tumor activity by delivering STING agonist specifically to tumor cells andFcγRI-expressing subset of myeloid cells
    Cetinbas, Naniye Malli
    Catcott, Kalli C.
    Monnell, Travis
    Soomer-James, Jahna
    Bentley, Keith
    Clardy, Susan
    Du, Bingfan
    Kelleher, Eoin
    Protopopova, Marina
    Stevenson, Cheri
    Thomas, Joshua D.
    Uttard, Alex
    Toader, Dorin
    Duvall, Jeremy
    Bukhalid, Raghida
    Damelin, Marc
    Lowinger, Timothy B.
    CANCER RESEARCH, 2022, 82 (12)
  • [22] CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells
    Chun, Inkook
    Kim, Ki Hyun
    Chiang, Yi-Hao
    Xie, Wei
    Lee, Yong Gu Gu
    Pajarillo, Raymone
    Rotolo, Antonia
    Shestova, Olga
    Hong, Seok Jae
    Abdel-Mohsen, Mohamed
    Wysocka, Maria
    Ballard, Hatcher J.
    Barrett, David M.
    Posey, Avery D.
    Powell, Daniel, Jr.
    Gill, Saar I.
    Schuster, Stephen J.
    Barta, Stefan K.
    Rook, Alain H.
    June, Carl H.
    Ruella, Marco
    BLOOD, 2020, 136
  • [23] Synthesis of novel resveratrol and quercetin derivatives: Anti-tumor activity on mouse T2A and T3PA cancer cells
    Bloom, Thomas D.
    Alburger, James
    Winkelbauer, Joseph
    Rzewnicki, Daniel
    Schmidt, Rachel
    Kriley, Charles E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [24] Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner
    Yaqub, Sheraz
    Henjum, Karen
    Mahic, Milada
    Jahnsen, Frode L.
    Aandahl, Einar M.
    Bjornbeth, Bjorn A.
    Tasken, Kjetil
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (06) : 813 - 821
  • [25] ARMORING NKG2D CAR T CELLS WITH IL-18 IMPROVES IN VIVO ANTI-TUMOR ACTIVITY
    Breman, Eytan
    Walravens, Ann-Sophie
    Gennart, Isabelle
    Velghe, Amelie
    Nguyen, Thuy
    Violle, Benjamin
    Huberty, Fanny
    Ramelot, Nancy
    Twyffels, Laure
    Gauthy, Emilie
    Iserentant, Hannes
    Gilham, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A118 - A118
  • [26] Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner
    Sheraz Yaqub
    Karen Henjum
    Milada Mahic
    Frode L. Jahnsen
    Einar M. Aandahl
    Bjørn A. Bjørnbeth
    Kjetil Taskén
    Cancer Immunology, Immunotherapy, 2008, 57 : 813 - 821
  • [27] Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
    Brown, Christine E.
    Aguilar, Brenda
    Starr, Renate
    Yang, Xin
    Chang, Wen-Chung
    Weng, Lihong
    Chang, Brenda
    Sarkissian, Aniee
    Brito, Alfonso
    Sanchez, James F.
    Ostberg, Julie R.
    D'Apuzzo, Massimo
    Badie, Behnam
    Barish, Michael E.
    Forman, Stephen J.
    MOLECULAR THERAPY, 2018, 26 (01) : 31 - 44
  • [28] SELECTIVE ACTIVATION OF CD8+T CELLS BY A CD8-TARGETED IL-2 RESULTS IN ENHANCED ANTI-TUMOR EFFICACY AND SAFETY
    Moynihan, Kelly
    Pappas, Danielle
    Park, Terrence
    Chen, Wei
    Ni, Irene
    Bessette, Paul
    Chin, Mike
    Schumacher, Ton
    Yeung, Andy
    Djuretic, Ivana
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A746 - A746
  • [29] PLX-4107, a selective IKZF2 degrader, reprograms suppressive regulatory T cells and demonstrates anti-tumor activity.
    Thompson, Peggy A.
    Yang, Pengyu
    Yang, Linette
    Song, Susan
    Huang, Yujun
    Li, Xiaoming
    Dearie, Alejandro
    Chien, Stephen
    Spalding, Mary E.
    Blanco, Gabrielle
    Daniele, Elizabeth
    Toth, Julia
    Jamborcic, Aleksandar
    Parker, Gregory
    Bailey, Simon
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [30] Outsmart™ IL-2/15, a Novel Cytokine Designed to Enhance ROR1-Specific CAR T Anti-Tumor Activity While Minimizing Treg Activation and Systemic Cytokine Exposure
    Moffett, Howell
    Weitzner, Brian
    Davenport, Thaddeus
    Tait, Leah
    Tan, Tina
    Baker, Laura
    Crowl, John
    Obenza, Willimark
    Hammerson, Bradley
    Kirkpatrick, Robin
    Sample, Paul
    Jones, Lesley
    Hermans, Erik
    Langan, Robert
    Haworth, Kevin
    Boyken, Scott
    Foster, Aaron
    Lajoie, Marc
    BLOOD, 2023, 142